Shu Yang

1.6k total citations
89 papers, 1.2k citations indexed

About

Shu Yang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Shu Yang has authored 89 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Epidemiology. Recurrent topics in Shu Yang's work include Liver Disease Diagnosis and Treatment (11 papers), Kruppel-like factors research (8 papers) and Cancer, Lipids, and Metabolism (7 papers). Shu Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Kruppel-like factors research (8 papers) and Cancer, Lipids, and Metabolism (7 papers). Shu Yang collaborates with scholars based in China, United States and Malaysia. Shu Yang's co-authors include Chuanrui Ma, Guangyan Yang, Zhen Liang, Xiaoxiao Yang, Yuanli Chen, Ke Feng, Lipei Liu, Yajun Duan, Han Wu and Lin Kang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Endocrine Reviews.

In The Last Decade

Shu Yang

82 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Yang China 22 513 201 177 157 108 89 1.2k
Xia Zhong China 19 423 0.8× 122 0.6× 198 1.1× 163 1.0× 158 1.5× 42 1.1k
Hui Lin China 22 642 1.3× 179 0.9× 154 0.9× 113 0.7× 122 1.1× 73 1.4k
Xiaowen Yu China 19 440 0.9× 139 0.7× 119 0.7× 119 0.8× 138 1.3× 46 1.1k
Jiagen Wen China 19 515 1.0× 145 0.7× 121 0.7× 101 0.6× 211 2.0× 47 1.1k
Tongda Xu China 23 480 0.9× 152 0.8× 119 0.7× 139 0.9× 65 0.6× 77 1.4k
Rong Hu China 16 551 1.1× 193 1.0× 97 0.5× 124 0.8× 54 0.5× 36 941
Chao Zheng China 21 454 0.9× 130 0.6× 139 0.8× 108 0.7× 89 0.8× 80 1.3k
Takafumi Nakao Japan 18 498 1.0× 120 0.6× 115 0.6× 200 1.3× 114 1.1× 59 1.3k
Ang Chen China 18 589 1.1× 104 0.5× 89 0.5× 126 0.8× 94 0.9× 35 1.1k

Countries citing papers authored by Shu Yang

Since Specialization
Citations

This map shows the geographic impact of Shu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Yang more than expected).

Fields of papers citing papers by Shu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Yang. The network helps show where Shu Yang may publish in the future.

Co-authorship network of co-authors of Shu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Yang. A scholar is included among the top collaborators of Shu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Yang. Shu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan-Chun, Lixing Li, Jiaqing Xiang, et al.. (2025). TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease. Cell Reports. 44(8). 116091–116091. 2 indexed citations
2.
Duan, Hui, et al.. (2025). Moisture absorption behavior of CFRP: Finite element analysis and machine learning coupled method. Journal of Reinforced Plastics and Composites. 45(7-8). 1877–1889. 1 indexed citations
3.
Wang, Wenjing, Sheng‐Hong Li, Xiaoju Cui, et al.. (2025). Anti-sulfur poisoning and highly sensitive portable detection instrument for monitoring of hydrogen sulfide on-site. Journal of Hazardous Materials. 492. 138278–138278.
5.
Zhao, Rui-Lin, Shu Yang, Wei Xu, et al.. (2024). The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis. Cancer Cell International. 24(1). 361–361. 2 indexed citations
6.
Sun, Hongyan, Dan Liu, Ting Meng, et al.. (2024). Indoxyl sulfate induces retinal microvascular injury via COX-2/PGE2 activation in diabetic retinopathy. Journal of Translational Medicine. 22(1). 870–870. 4 indexed citations
7.
Yang, Shu, Shangjing Liu, Yifan Wu, et al.. (2024). The plant extract PNS mitigates atherosclerosis via promoting Nrf2‐mediated inhibition of ferroptosis through reducing USP2‐mediated Keap1 deubiquitination. British Journal of Pharmacology. 181(23). 4822–4844. 8 indexed citations
8.
Yang, Shu, Guangyan Yang, Jiaqing Xiang, et al.. (2024). KLF13 restrains Dll4‐muscular Notch2 axis to improve the muscle atrophy. Journal of Cachexia Sarcopenia and Muscle. 15(5). 1869–1882. 1 indexed citations
9.
Wang, X., et al.. (2024). Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of NHANES 2003 to 2018. The Journal of Clinical Endocrinology & Metabolism. 109(12). e2324–e2333. 23 indexed citations
10.
Yang, Shu, Yunfan Liu, Yiru Gao, & Jiaying Li. (2023). pH-Triggered mitochondria targeting fluorescent probe for detecting Monoamine Oxidases A in living cells. Sensors and Actuators B Chemical. 390. 133912–133912. 10 indexed citations
11.
Li, Qian, Huadong Guo, Lei Luo, Xinyuan Wang, & Shu Yang. (2023). Impact Analysis of Land Use and Land Cover Change on Karez in Turpan Basin of China. Remote Sensing. 15(8). 2146–2146. 2 indexed citations
12.
Wang, Xiaohao, et al.. (2023). Mitochondrial disorders as a mechanism for the development of obese Sarcopenia. Diabetology & Metabolic Syndrome. 15(1). 224–224. 6 indexed citations
13.
Yang, Shu, Jiaqing Xiang, Chuanrui Ma, et al.. (2023). Sp1-like protein KLF13 acts as a negative feedback regulator of TGF-β signaling and fibrosis. Cell Reports. 42(4). 112367–112367. 9 indexed citations
14.
Yang, Shu, Han Wu, Yan-Chun Li, et al.. (2023). Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis. Cell Death and Disease. 14(12). 816–816. 25 indexed citations
15.
Yang, Shu, Xinyu Wang, Lixing Li, et al.. (2023). MicroRNA‐92b in the skeletal muscle regulates exercise capacity via modulation of glucose metabolism. Journal of Cachexia Sarcopenia and Muscle. 14(6). 2925–2938. 4 indexed citations
17.
Yang, Shu, et al.. (2023). SIRT2 alleviated renal fibrosis by deacetylating SMAD2 and SMAD3 in renal tubular epithelial cells. Cell Death and Disease. 14(9). 646–646. 21 indexed citations
18.
Yang, Shu, Jiaqing Xiang, Guangyan Yang, et al.. (2022). KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7. EMBO Reports. 23(6). e54229–e54229. 24 indexed citations
19.
Yang, Shu, Guangyan Yang, Han Wu, et al.. (2021). MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway. Diabetologia. 65(3). 563–581. 15 indexed citations
20.
Ma, Chuanrui, Ke Feng, Xiaoxiao Yang, et al.. (2021). Targeting macrophage liver X receptors by hydrogel‐encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis. British Journal of Pharmacology. 178(7). 1620–1638. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026